Article routing is now being used to connect geo-led market reports back into the commercial sector architecture, creating a clearer authority graph for this market.
These articles are already mapped into this pillar or one of its child sectors, which makes this a useful editorial routing layer even before a full insights redesign.
Winston-Salem's regenerative medicine cluster has spent two decades earning a reputation as one of the most productive sources of tissue engineering...
Waterford's medtech sector entered 2026 with a paradox embedded in its foundation. The physical infrastructure is expanding.
Ulm's medical technology cluster entered 2026 with a contradiction that no amount of research excellence can resolve on its own.
Tijuana's medical device cluster now operates at roughly 89% capacity utilisation across 73 active manufacturing facilities.
Tacoma's two largest health systems have committed more than $630 million to expanding clinical capacity in the city.
Songdo International Business District was designed as a single coherent city. In 2026, it operates as two.
Skopje's pharmaceutical sector exported €265 million worth of product in 2023. Alkaloid AD, the company responsible for roughly 85 to 90 per cent of...
Shreveport's two dominant health systems have committed nearly $180 million in capital projects since 2022. Willis-Knighton is building a $45 million...
Scottsdale's biomedical sector added 18,400 direct jobs within city limits by late 2024, a 12.3% increase from 2022 that outpaced the national sector...
The layoffs were supposed to release talent into the market. In August 2023, Medtronic announced the elimination of 300 positions at its Santa Rosa campus,...
San Diego delivered 1.2 million square feet of new laboratory space in 2024, with another 2.8 million in the pipeline through 2026.
The BioHive cluster entered 2026 with a paradox that defines its talent market. One of its anchor companies eliminated 100 positions in late 2024 while...
Pune produced over 1.5 billion vaccine doses in 2025 through a single facility. The city hosts more than 150 US FDA-approved manufacturing plants, the...
Providence's life sciences sector has never been larger, better funded, or more structurally vulnerable.
Philadelphia's Cellicon Valley corridor entered 2026 with 23 Phase III cell and gene therapy trials, $1.2 billion in fresh venture capital deployed across...
Petah Tikva exported approximately $4 billion in pharmaceutical products last year, accounting for nearly half of Israel's total pharma exports.
Penang's medical device sector approved RM 8.2 billion in manufacturing investment during 2024. That figure is projected to approach RM 10 billion by the...
Pasadena's biotechnology sector is not a cluster in the conventional sense. It is, for most practical purposes, one company's clinical operation...
Chiesi Farmaceutici's €45 million cell therapy manufacturing expansion became operational in Parma in 2024. The facility produces lentiviral vectors for...
Stanford Research Park sits at the heart of one of the most concentrated life sciences clusters in the United States.
Oulu's health technology cluster generated an estimated €420 million in revenue in 2024, with export intensity exceeding 85% of production value.
Krka d.d. completed its €200 million Solid Dosage Forms Plant 2 in late 2024, adding 150,000 square metres of production space and increasing tablet and...
Nicosia's professional services sector was built on a specific premise. Cyprus offered international businesses a compliant, EU-member jurisdiction with...
New York City added roughly 450,000 square feet of wet-lab capable space in Long Island City alone through late 2024, with another 600,000 square feet...
Share your CV with us.